Delivery Order SPE2DB22D3301-SPE2DB25FY2PV

Award Date 4/2/25
Potential Completion Date 4/3/25
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LIDOCAINE 5% PATCH 30S, a medical product, with a ceiling value of $4,626.25 and a performance period through March 26, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,486.40 and is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 12, 2024. The contract was not set aside for any specific business type. Amerisourcebergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LIDOCAINE 5% PATCH 30S medical products, with a ceiling value of $1,361.04 and a period of performance through March 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, with a ceiling value of $2,797.32 and a period of performance through May 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $1,397.16 and is a firm fixed-price delivery order with a completion date of May 16, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of LIDOCAINE 5% PATCH 30S, a medical product, with a ceiling value of $4,746.37 and a completion date of March 8, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568376045 LIDOCAINE 5% PATCH 30S, a medical product, with a ceiling value of $2,707.08 and a performance period ending on May 29, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of LIDOCAINE 5% PATCH 30S, a pain relief medication, with a ceiling value of $2,630.17 and an ultimate completion date of April 9, 2025. The contract is an Indefinite Delivery Contract (IDC) vehicle that enables the DLA to efficiently procure a wide range of pharmaceutical and medical products to support military...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,612.97 and is for the supply of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract is a firm fixed price delivery order, with an ultimate completion date of July 26, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,149.15, is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 8, 2025. This contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY2PV
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has a ceiling value of $5,251.16 and a period of performance through April 3, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/2/25, 11:07 PM